You searched for ms-qava – enQuire BioReagents

Anti-Catenin, beta Antibody Clone 5H10

Additionally, this antibody has been validated by MS–QAVA™.

Anti-Cytokeratin 8/18 Antibody Clone KRT8.18/1346

Additionally, this antibody has been validated by MS–QAVA™.

Anti-p21WAF1 Antibody Clone CIP1/823

Additionally, this antibody has been validated by MS–QAVA™.

Anti-MCM7 Antibody Clone MCM7/1468

$Analysis of Mass Spec data (dashed-line) of fractions stained with MCM7 MS-QAVA™ monoclonal antibody [Clone: MCM7/1468] (solid-line), reveals that less than 3.8% of signal is attributable to non-specific binding of anti-MCM7 [Clone: MCM7/1468] to targets other than MCM7 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in A431, RT4 and MCF7 cells.$

Additionally, this antibody has been validated by MS–QAVA™.

Anti-Bax Antibody Clone 2D2

Additionally, this antibody has been validated by MS–QAVA™.

Anti-CD44 / HCAM Antibody Clone HCAM/918

$Analysis of Mass Spec data (dashed-line) of fractions stained with CD44 / HCAM MS-QAVA™ monoclonal antibody [Clone: HCAM/918] (solid-line), reveals that less than 12.6% of signal is attributable to non-specific binding of anti-CD44 / HCAM Std. Anti-Human, Primate [Clone HCAM/918] to targets other than CD44 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in Jurkat, U202 and HeLa cells.$

Additionally, this antibody has been validated by MS–QAVA™.

Anti-Cytokeratin 7 Antibody Clone KRT7/1499R

$Analysis of Mass Spec data (dashed-line) of fractions stained with Cytokeratin 7 MS-QAVA™ monoclonal antibody [Clone: KRT7/1499R] (solid-line), reveals that less than 13.6% of signal is attributable to non-specific binding of anti-Cytokeratin 7 [Clone KRT7/1499R] to targets other than KRT7 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in A431, RT4 and MCF7 cells.$

Additionally, this antibody has been validated by MS–QAVA™.

Anti-p53 Tumor Suppressor Protein Antibody Clone BP53-12 + DO-7

$Analysis of Mass Spec data (dashed-line) of fractions stained with p53 Tumor Suppressor Protein MS-QAVA™ monoclonal antibody [Clone: BP53-12 + DO-7] (solid-line), reveals that less than 10.8% of signal is attributable to non-specific binding of anti-p53 Tumor Suppressor Protein [Clone BP53-12 + DO-7] to targets other than TP53 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in A431, RT4 and MCF7 cells.$

Additionally, this antibody has been validated by MS–QAVA™.

Anti-ZAP70 Antibody Clone 2F3.2

Staining with mouse monoclonal ZAP70 [Clone 2F3.2] antibody in formalin-fixed paraffin-embedded human tonsil.

Additionally, this antibody has been validated by MS–QAVA™.

Anti-SUMO-1 Antibody Clone SUMO1/1188

Additionally, this antibody has been validated by MS–QAVA™.

Anti-Vimentin Antibody Clone VM1170

Additionally, this antibody has been validated by MS–QAVA™.

Anti-p21WAF1 Antibody Clone DCS-60.2

Additionally, this antibody has been validated by MS–QAVA™.

Anti-CD3e Antibody Clone C3e/1308

Additionally, this antibody has been validated by MS–QAVA™.

Anti-Catenin, beta Antibody Clone 6F9

$Analysis of Mass Spec data (dashed-line) of fractions stained with Catenin, beta MS-QAVA™ monoclonal antibody [Clone: 6F9] (solid-line), reveals that less than 5.2% of signal is attributable to non-specific binding of anti-Catenin, beta [Clone: 6F9] to targets other than CTNNB1 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in A431, RT4 and MCF7 cells.$

Additionally, this antibody has been validated by MS–QAVA™.

Anti-EpCAM / CD326 Antibody Clone EGP40/1372

Additionally, this antibody has been validated by MS–QAVA™.

Anti-Cdk1 / p34cdc2 Antibody Clone CDK1/873

$Analysis of Mass Spec data (dashed-line) of fractions stained with Cdk1 / p34cdc2 MS-QAVA™ monoclonal antibody [Clone: CDK1/873] (solid-line), reveals that less than 1.4% of signal is attributable to non-specific binding of anti-Cdk1 / p34cdc2 [Clone CDK1/873] to targets other than CDC2 protein. Even frequently cited antibodies have much greater non-specific interactions, averaging over 30%. Data in image is from analysis in Jurkat, U202 and HeLa cells.$